ArticleOncoimmunology2020

LAG-3 and PD-1+LAG-3 inhibition promote anti-tumor immune responses in human autologous melanoma/T cell co-cultures.

Nicolas Gestermann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.